A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System
Launched by ELLIPSE TECHNOLOGIES, INC. · Oct 26, 2012
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Early onset spinal deformity with any etiology
- • Cobb angle measurement of 30 degrees or greater at the time of primary surgery
- • Thoracic spine height (T1 to T12) less than 22 cm at the time of primary surgery
- • Age less than 11 years old at the time of MAGEC implant
- • Implanted with the MAGEC system as either a primary or secondary revision spinal bracing procedure
- • Patient has been implanted for a minimum of 6 months
- • Patient signs informed consent for the use of their personal private data
- Exclusion Criteria:
- • Patient declines to sign informed consent for the use of their personal private data.
About Ellipse Technologies, Inc.
Ellipse Technologies, Inc. is a pioneering clinical trial sponsor specializing in the development of innovative medical devices and solutions that enhance patient care and outcomes. Focused on advancing orthopedic and spinal applications, the company is dedicated to conducting rigorous clinical trials that adhere to the highest standards of safety and efficacy. By leveraging cutting-edge technology and a commitment to scientific excellence, Ellipse Technologies aims to transform the landscape of healthcare through the successful introduction of novel therapies that address unmet clinical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Auckland, , New Zealand
Turku, , Finland
Turku, , Finland
Ankara, , Turkey
Hong Kong, , Hong Kong
Cairo, , Egypt
Helsinki, , Finland
Bologna, , Italy
Rome, , Italy
Ankara, , Turkey
Istanbul, , Turkey
Istanbul, , Turkey
Izmir, , Turkey
Stanmore, Middlesex, United Kingdom
Cardiff, , United Kingdom
London, , United Kingdom
Patients applied
Trial Officials
Behrooz A Akbarnia, MD
Principal Investigator
San Diego Center for Spinal Disorders
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials